Our data revealed that prior to hornerin knockdown and 4 days post initiation of AV-951 treatment, there was no difference in either tumor blood hemoglobin or oxygen saturation as determined by PAM (Fig. 7a, b (day 5). The gene discussed is HRNR; the disease is neoplasm.